[Ketum "forces" its way back on the market. What is the price of a serious adverse event?].
J-C
JC
Beani
M
M
Avenel-Audran
A
A
Barbaud
J
J
Revuz
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects*; D017277:Drug Approval; D005602:France; D006801:Humans; D007660:Ketoprofen / Q000009:adverse effects*; D010787:Photosensitivity Disorders / Q000139:chemically induced*
D000894:Anti-Inflammatory Agents, Non-Steroidal; D007660:Ketoprofen
Ketum remis << de force >> sur le marché. Quel est le prix d'un effet indésirable grave ?